Coronary Artery Bypass Graft Market – By Product, By Method, By Surgery Type, By End Use – Global Forecast, 2024 to 2032

Coronary Artery Bypass Graft Market Size

The global coronary artery bypass graft market size was valued at USD 11.8 billion in 2023 and is estimated to grow at 7.1% CAGR over the analysis timeline. Coronary artery bypass grafting (CABG) is used in the management of coronary artery disease (CAD). The procedure involves the use of a graft to restore blood flow to the heart. Often, this involves taking a section of a blood vessel from the saphenous vein in the leg or using the internal mammary artery from the chest.
 

The rising incidence of coronary heart disease is resulting in growth of the coronary artery bypass graft (CABG) market across the globe. Cardiovascular diseases have emerged as the leading cause of deaths worldwide, accounting for around 17.9 million deaths per year, as per the World Health Organization (WHO). The increasing prevalence of chronic diseases like diabetes and pulmonary arterial hypertension are other factors responsible for this growth. High levels of blood glucose can affect the blood vessels that go to the heart and lead to heart problems.
 

In addition, the market is driven by the increasing elderly population, which the United Nations estimates will be 2.1 billion by 2050, effectively doubling in number. The gradual development of deposits of fats in the arterial walls makes older people more vulnerable to developing cardiovascular illnesses, which is where CABG comes in as an operative procedure that helps them. Aside from the elderly citizens, appropriate reimbursement policies are further encouraging the CABG market's expansion, increasing the use of the surgery. Collectively, these trends highlight the increasing significance of CABG in the fight against the global burden of cardiovascular diseases.
 

Coronary Artery Bypass Graft Market Trends

• Robotic-assisted minimally invasive surgeries have a shorter recovery period than traditional methods, and hence the former is becoming more sought after than the latter. Precise and effective are the endoscopic-assisted CABG procedures and robotic CABG procedures that are now widely used by patients as well as surgeons.
   
•   With a limited duration of hospital stay and faster healing, CABG is associated with the beating heart CABG as it exposes the patient to the operative procedure. As technology and skills continue to advance, this method should also continue to develop.
   
• In addition, hybrid techniques for revascularization that utilize both CABG and Percutaneous coronary interventions (PCI) are becoming a well-accepted method for the treatment of patients with multi-vessel coronary artery disease. Such an approach integrates the benefits of both surgical and non-surgical approaches for treating multi-vessel disease and hence is more effective.
   
•   Similarly, off-pump CABG and OPCAB seem to have more advantages than displacing the heart-lung machine for patients and surgeons as it decreases bleeding and even cognitive dysfunction. OPCAB is well indicated in high-risk patients with aims to provide shorter recovery times compared to traditional approaches.
   

Coronary Artery Bypass Graft Market Analysis

The market is segmented into grafts, retractors, heart positioners, tissue stabilizers, and other products based on product. The grafts segment is further sub-segmented into saphenous vein grafts, internal thoracic artery grafts, and other grafts. The grafts segment dominated the market with the largest revenue of USD 3.1 billion in 2023.
 

• Manufacturing methods have improved with the introduction of 3D printing and tissue engineering to the point that it can enable the manufacturing of grafts that are highly biocompatible and mimic human blood vessels. Such improvements will make CABG highly effective and grafts more in demand as they will mitigate various complications and enhance acceptability as well as optimize the rejection rate.
   
• The introduction of synthetic, bioengineered, and drug-eluting grafts has enhanced the outcomes of surgery. These materials boast greater durability and compatibility while also reducing the chances of restenosis. The means for the devices also encourage better patient recovery. Hence these factors synergistically grow the market.
   
• Recent trends show that there is a shift towards hybrid coronary revascularization where CABG and PCI are combined. This shift is more common in complex cases. These hybrid procedures are commonly done with traditional and even synthetic grafts, increasing the market for that form of graft.
   

Based on method, the coronary artery bypass graft market is bifurcated into traditional (on-pump) CABG and minimally invasive direct CABG. The traditional (on-pump) CABG segment dominated the market with the largest revenue share of 55.1% in 2023.
 

• The increasing cases of coronary artery disease at global include the need for coronary artery bypass grafting or CABG surgery. The most common type of heart disease is coronary heart disease, which results in approximately 375,476 deaths a year. Every year, around 805,000 heart attacks occur in the U.S., making traditional CABG vital due to such startling statistics.
   
• Moreover, the currently increasing lifestyles that involve minimal physical activity, poor diets, and the growing percentage of diabetes patients and patients suffering from hypertension are risk factors for CAD, which in turn increases the role of CABG surgery to improve the quality of life of patients.
   
• In addition, the on-pump CABG is the method of choice for the majority of complex operations, especially in cases of multi-vessel disease where accuracy and control are very important. The heart-lung machine employed in on-pump CABG makes for a bloodless surgical field, thus enabling surgeons to operate on risky and complex cases; this is one factor that has kept the procedure in demand amongst surgeons and cardiologists.
   
• Such factors provided above are likely to have a considerable impact on the growth of the segment in the forecast period.
   

The coronary artery bypass graft market is segmented into single CABG surgery, double CABG surgery, triple CABG surgery, and quadruple CABG surgery based on surgery type. The single CABG surgery segment is projected to reach USD 7.1 billion by 2032.
 

• Single CABG is indicated in patients with single vessel disease, are not suitable for multi-vessel bypass surgery since it is performed through a small incision, making it extremely handy with minimal invasiveness. Furthermore, the rise in use of surgical robots that are adept at performing complex surgeries which are optimally invasive is further adding to the demand for such treatment options for coronary artery disease.
   
• The ever-increasing elderly population is one of the major reasons fueling the single CABG market. Indeed, they are more prone to coronary artery disease and its associated congestion. Single CABG, however, is favored for elderly, have isolated lesions and would be treated with low-risk interventions.
   
• The World Health Organization indicates that those aged 60 years and older will increase from 1 billion in 2020 to 2.1 billion by 2050. This scenario is beneficial particularly for the progressing age group because this will incur less surgical risk. Older patients will welcome the single CABG approaches as they are somewhere between the cheap and the moderately expensive in terms of surgical risk.
   
• Thus, the above-mentioned aspects are predicted to facilitate the expansion of this segment in the following years.
   

The coronary artery bypass graft market is segmented by end use into hospitals, cardiology centers, and other end users. In 2023, the hospitals segment was valued at USD 5.3 billion.
 

• CVD is one of the commonest causes of death across the globe, and they naturally use large numbers of CABG's while in hospital. The World Health Organization (WHO) asserts that cardiovascular diseases account for 31% of worldwide deaths. Such figures on the high burden of cardiovascular disease will show the sustained demand for CABG in the hospital.
   
• Hospitals have special facilities fitted with advanced heart-lung machines, and they often contain intensive care units as well as specialized operating rooms. With such sophisticated amenities at hand, CABG surgeries will be both safe and effective, thus making hospitals the most suited location for performing such surgical procedures.
   
• Furthermore, these vessels are frequently found in multi-vessel disease, which accounts for the greater part of CAD cases that require surgery and are most often conducted in hospitals. Multi-vessel disease also requires a controlled environment as well as surgical expertise that are only available in a hospital setting, where a sufficient level of concentration is required to perform CABG.
   

The U.S. coronary artery bypass graft market was valued at USD 3.5 billion in 2023 and is expected to grow at a CAGR of 6.7% over the forecast period.
 

• Coronary artery diseases (CRD) is becoming more accessible because of the rapid technological advance in US hospitals. Recently, there has been a rise in the use of robotic-assisted surgeries, which means that the recovery time is much lower. In addition, the post-surgical complications are also much less now. This allows for CABG to be much more in demand.
   
• An increment in multi-vessel disease, which is characterized by multiple blockages in one or more than one coronary artery, is being experienced in the U.S. market, and this is where CABG comes into play. Percutaneous coronary intervention (PCI)  might not be the best option for those patients, and researchers believe that CABG is perfect for more advanced cases of coronary artery disease.
   
• According to the National Institutes of Health stated that there are around 400,000 CABG procedures that are carried out in the U.S. on a yearly basis, and there is strong evidence supporting the fact that this number will only increase as time passes by.
   
• The region's development is bound to increase in the next couple of years owing to the earlier mentioned factors.
   

The coronary artery bypass graft market in the UK is expected to experience significant growth from 2024 to 2032.
 

• The increasing prevalence of conditions such as diabetes and hypertension in the UK is resulting in pronounced risk factors for CAD.
   
• For instance, as per Diabetes UK, the number of diabetics in the UK is approximately 5.6 million; for hypertensives, the range is even bigger, reaching about 26-28% of England's population. This combined growing prevalence increases the patient pool that has CABG done in order to prevent further complications with the heart. This shift in focus highlights the increasing role of CABG in dealing with the CAD burden in the UK.
   
• Targeting the long waiting period for procedures including CABG as a key optimization factor, the NHS has allocated resources and streamlined processes to facilitate patients more easily qualifying for the procedure – referral pathways to other medical providers are more intuitive, and there is more focus on the right level of care being provided timely.
   
• For example, it is planned that the number of scheduled procedures will rise significantly by fiscal year 2023/24 in accordance with the NHS Long Term Plan. With this constant outreach, the waiting time and accessibility improves, and this encourages an increase in the coronary bypass operations that are carried out. Because of the growing education and government initiatives, it is anticipated that the region's economic growth will be accelerated substantially in the future.
   

The Japan coronary artery bypass graft market is anticipated to witness substantial growth between 2024 – 2032.
 

• Life expectancy varies in accordance with gender in Japan. For instance, in 2020 a Japanese woman can expect to live for approximately 87.1 years while a man, about 81.0 years. With such an age lot, as per BBC World Service, Japan's population is aging rapidly, with 29.1% estimate of citizens aged 65 and older.
   
• The aging of this population leads to an increased frequency of age-related cardiovascular diseases. This demographic trend drives the number of coronary artery bypass graft (CABG) surgeries performed, especially for some patients who have suffered from coronary artery disease (CAD).
   
• In this respect, Japan also joins the bandwagon of countries with enhanced robotic techniques aiming at making CABG less invasive. Such new developments improve surgical results and reduce rehabilitation intervals thereby making CABG increasingly attractive to patients and thereby improving market growth.
   
• In the light of these, the below factors are expected to support the growth of the region during the forecast horizon.
   

The coronary artery bypass graft market in Saudi Arabia is expected to experience significant growth from 2024 to 2032.
 

• The Saudi Vision 2030 aims to motivate investments in the health sector by the government of Saudi Arabia. Such investments are aimed at constructing new healthcare facilities and augmenting existing ones, which include building more specialized cardiac care units focused on increasing CABG surgery capabilities of the country.
   
• Moreover, Saudi Arabia is diversifying its services and becoming a hub for medical tourism, attracting patients from the region looking for better treatment. Availability of specialized cardiac procedures, for instance, CABG, can attract foreign patients, further increasing the demand for the surgeries in the country.
   
• Thus, the above-discussed parameters are likely to propel the market growth in the region in the next few years.
   

Coronary Artery Bypass Graft Market Share

The market is highly competitive, with a large number of global size and small to medium commercial centers fighting for the same share of the market. One of the dimensions of the market strategy is based on the introduction of new ever-cutting edge products using technology variety. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving the market growth. Furthermore, winners and losers emerge due to strategic coalitions, acquisitions, and mergers strengthening market positions or obtaining wider global markets under changing regulation.
 

Coronary Artery Bypass Graft Market Companies

Some of the eminent market participants operating in the coronary artery bypass graft industry include:

• Abbott Laboratories
• AngioDynamics
• AtriCure
• B. Braun Melsungen AG
• Boston Scientific
• Cardinal Health
• CryoLife
• Edwards Lifesciences
• Johnson & Johnson
• LivaNova
• Medline Industries
• Medtronic
• Nipro Corporation
• Stryker Corporation
• Terumo Corporation
   

• Abbott Laboratories, well developed in the field of advanced minimally invasive technologies, Abbott leads the market with its proprietary heart pumps and vascular grafts that increase surgical precision, results, and patients' recovery times.
   
• Medtronic’s vast network of global R&D, the company is always on the cutting edge of cardiology and produces a steady stream of advanced products targeted for coronary artery bypass graft surgery.
   
• Boston Scientific, a well-known market leader in materials science, Boston Scientific expands its boundaries by forming partnerships for the purpose of designing innovative patch materials for clinical needs.
   

Coronary Artery Bypass Graft Market Industry News

• In August 2024, DePuy Synthes announced the launch of the MatrixSTERNUM Fixation System. This plate and screw fixation system was designed to stabilize and secure the front part of the chest wall following procedures such as open-heart surgery and chest surgery. This launch is anticipated to enhance DePuy Synthes' portfolio in thoracic surgical solutions.
   
• In October 2023, SS Innovations International, Inc., a developer of advanced surgical robotic technologies, launched a robotic cardiac surgery program in India featuring its flagship SSi Mantra surgical robotic system. The program aimed to revitalize robotic coronary artery bypass and intracardiac surgery in India and to train surgeons nationwide in these specialized procedures with the SSi Mantra. This launch was anticipated to strengthen SS Innovations International, Inc.'s market presence in India, drive innovation in cardiac surgery, and position the company as a leader in the expanding field of robotic surgical technologies.
   

The coronary artery bypass graft market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Grafts
  • Saphenous vein grafts
  • Internal thoracic artery grafts
  • Other grafts
• Retractors
• Heart positioners
• Tissue stabilizers
• Other products

Market, By Method

• Traditional (on-pump) CABG
• Minimally invasive direct CABG
  • Off-pump CABG
  • Keyhole CABG
  • Other minimally invasive CABG surgeries

Market, By Surgery Type

• Single CABG surgery
• Double CABG surgery
• Triple CABG surgery
• Quadruple CABG surgery

Market, By End Use

• Hospitals
• Cardiology centers
• Other end users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
• Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacifi 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE